CVS - CVS Health Corporation

NYSE - NYSE Delayed Price. Currency in USD
73.37
-1.13 (-1.52%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close74.50
Open74.36
Bid0.00 x 800
Ask0.00 x 39400
Day's Range72.32 - 74.57
52 Week Range60.14 - 83.88
Volume10,693,916
Avg. Volume8,537,567
Market Cap94.882B
Beta (3Y Monthly)1.03
PE Ratio (TTM)24.13
EPS (TTM)3.04
Earnings DateFeb 6, 2019 - Feb 11, 2019
Forward Dividend & Yield2.00 (2.70%)
Ex-Dividend Date2018-10-23
1y Target Est93.15
Trade prices are not sourced from all markets
  • Asian shares fall on poor Chinese economic data
    Associated Press2 hours ago

    Asian shares fall on poor Chinese economic data

    Asian markets tumbled on Friday after China reported weaker-than-expected economic data, stirring up worries about the state of the world's second largest economy. KEEPING SCORE: Japan's Nikkei 225 index slid 1.7 percent to 21,439.16 and the Kospi in South Korea lost 1.2 percent to 2,070.70.

  • Zacks8 hours ago

    Buy Amazon (AMZN) Stock on the Dip Heading into 2019?

    Amazon (AMZN) stock has fallen over 16% in the last three months as part of the larger market pullback driven by the likes of Apple (AAPL) and other giants. The company's days of 40% top-line growth might also be over. But let's dive into Amazon's overall business picture and outlook to see if investors should buy AMZN stock heading into 2019.

  • Associated Press8 hours ago

    CVS and Delta fall while Aflac and General Electric jump

    Stocks that moved substantially or traded heavily Thursday: CVS Health Corp., down $1.13 to $73.37 The New York Post reported that a judge might bar CVS from integrating its business with health insurer ...

  • TheStreet.com8 hours ago

    U.S. Stocks Close Mixed After Late Rally; GE, P&G Gain

    The Dow Jones Industrial Average rose Thursday as Wall Street expressed optimism over U.S. and China trade talks. said Thursday it would invest $1 billion to build a new campus in Austin, Texas. Stocks traded mixed on Thursday, Dec. 13, as Wall Street monitored trade developments between the U.S. and China, the world's two largest economies.

  • InvestorPlace14 hours ago

    Best Stocks for 2019: Teladoc Health Looks Healthy for 2019

    Jason Moser’s pick for the contest is Teladoc Health (NASDAQ:TDOC). Thankfully, virtual healthcare provider Teladoc Health (NASDAQ:TDOC) is leveraging medical expertise to impact consumers around the world and offer them more options in a market which seems mired in red tape. While the concept of telehealth is still new to many, it is being seen more and more as an excellent option in many cases and the investments Teladoc is making in its business today could pay off big down the road as telehealth becomes a more meaningful part of the overall healthcare industry.

  • Motley Fool15 hours ago

    Top 10 Healthcare Stories of 2018

    New drugs, trial flops, M&A, and a little bit of everything else that happened in healthcare in 2018.

  • TheStreet.com18 hours ago

    Apple, Adobe, Huawei, CVS and Boy Scouts - 5 Things You Must Know

    U.S. stock futures were mixed on Thursday, Dec. 13, and shares in Asia closed higher as trade tensions eased between the U.S. and China, the world's two largest economies. Wall Street finished higher on Wednesday, Dec. 12, as investors cheered progress in U.S.-China trade talks and after a report said China was planning a new program that promised greater access for foreign companies. The Wall Street Journal reported Wednesday that China was drafting a replacement for Made in China 2025 - President Xi's blueprint to make the country a leader in high-tech industries - which would play down China's bid to dominate manufacturing and be more open to participation by foreign companies.

  • 10 Can’t-Miss Dividend Growth Stocks to Buy
    InvestorPlace2 days ago

    10 Can’t-Miss Dividend Growth Stocks to Buy

    Dividend growth stocks have obvious appeal. After all, dividend investing is based on buying and holding a stock for the payouts. Unlike traditional growth investing, where you depend on a stock increasing in value based on profits or sales trends, dividend investing focuses on the payouts above all else.

  • Zacks2 days ago

    CVS Health Aetna Synergy Impressive, PBM Selling Season Solid

    CVS Health (CVS) estimates a $750-million earning from near-term synergies with low- to mid-single digit addition in the second year after the closure of Aetna transaction.

  • CNBC2 days ago

    In acquiring Aetna, CVS embarks on another pivotal moment in its 55-year history

    CVS Health acquired health insurance giant Aetna for about $70 billion. CVS has bought other pharmacies to build its footrprint, as well as pharmacy benefit manager Caremark and walk-in health clinic MinuteClinic. It's buying a health insurer to prove it.

  • The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle
    Zacks2 days ago

    The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle

    The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle

  • TheStreet.com3 days ago

    Expect Less M&A in 2019 as Big Year Comes to a Close

    To start 2018, many on Wall Street were predicting a great year for stocks, as Donald Trump's tax plan was expected to produce elevated mergers and acquisitions activity. The deal activity has certainly been a part of the 2018 story, but the trend could slow down in 2019, said analysts from Goldman Sachs. Deal announcements are expected to increase 20% year over year in 2018, according to a note from Goldman that was released Tuesday.

  • CNBC3 days ago

    Stocks making the biggest moves premarket: DSW, F, GM, CVS, PFE & more

    These are the stocks posting the largest moves before the bell.

  • CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
    Zacks3 days ago

    CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

    CVS Health (CVS) closed at $73.34 in the latest trading session, marking a -1.01% move from the prior day.

  • Which Stocks Are The Best Mutual Funds Buying? Berkshire, Starbucks, Adobe Make The List
    Investor's Business Daily3 days ago

    Which Stocks Are The Best Mutual Funds Buying? Berkshire, Starbucks, Adobe Make The List

    The latest list of new buys by the best mutual funds shows a focus on large cap stocks like Berkshire, led by Warren Buffett, CVS, Starbucks and Adobe.

  • Hedge Funds Are Buying CVS Health Corporation (CVS)
    Insider Monkey5 days ago

    Hedge Funds Are Buying CVS Health Corporation (CVS)

    Is CVS Health Corporation (NYSE:CVS) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from industry insiders. They sometimes fail miserably but historically their consensus stock picks outperformed the market […]

  • The Wall Street Journal7 days ago

    [$$] Walgreens Launches Next-Day Prescription Home Delivery With FedEx

    Walgreens Boots Alliance Inc. has teamed up with FedEx Corp. to launch a nationwide next-day prescription home-delivery service as the drugstore chain works to stave off competition from Amazon.com Inc. and other rivals. Under the delivery service called Walgreens Express, patients enrolled in text alerts will receive text notification when qualifying prescriptions are ready, Walgreens said Thursday. For a $4.99 fee, patients can have their prescriptions delivered by FedEx to their home as early as the next day.

  • Why Is CVS Health (CVS) Up 0.2% Since Last Earnings Report?
    Zacks8 days ago

    Why Is CVS Health (CVS) Up 0.2% Since Last Earnings Report?

    CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Reuters8 days ago

    Walgreens to link up with FedEx on next-day drug delivery as Amazon nears

    In the race to make inroads in the on-demand drug delivery space, Walgreens' move could potentially put it head-to-head with Amazon.com Inc, which earlier this year said it would buy online pharmacy PillPack. Amazon's entry in the market would rattle traditional drug retailers and could potentially disrupt major players the U.S. drug supply chain. Rival CVS Health Corp launched its own next-day delivery service earlier this year.

  • Walgreens expands prescription delivery program nationwide
    Associated Press8 days ago

    Walgreens expands prescription delivery program nationwide

    Walgreens is joining rival drugstore chain CVS Health in expanding home deliveries for prescriptions nationwide, as stores continue adjusting to a retail world made more consumer-friendly by online competition. Walgreens said Thursday it will partner with FedEx to deliver prescriptions as soon as the next day for a $4.99 fee, and it also is providing same-day deliveries in several cities including New York, Chicago and Dallas. Walgreens and FedEx Corp. began a partnership last year where the drugstore chain started offering package drop-off and pick-up services at several thousand stores.

  • Reuters8 days ago

    Walgreens to link up with FedEx on next-day drug delivery as Amazon nears

    Walgreens Boots Alliance said on Thursday it would partner with FedEx Corp to launch a next-day delivery service for prescription drugs nationwide, giving it a leg up as Amazon threatens to shake-up the sector. In the race to make inroads in the on-demand drug delivery space, Walgreens' move could potentially put it head-to-head with Amazon.com Inc, which earlier this year said it would buy online pharmacy PillPack. Amazon's entry in the market would rattle traditional drug retailers and could potentially disrupt major players the U.S. drug supply chain.

  • CNBC8 days ago

    Stocks making the biggest moves premarket: FB, GOOG, SIG, CVS, THO & more

    These are the stocks posting the largest moves before the bell.

  • CVS Hears Trump, But Don't Count on Lower Drug Prices
    Bloomberg8 days ago

    CVS Hears Trump, But Don't Count on Lower Drug Prices

    The company announced a new pricing model for its pharmacy benefit management services Wednesday morning. The White House has been an active critic of PBMs, which negotiate drug discounts on behalf of employers and health plans, arguing that they have distorted the drug-pricing system. Drugmakers pay rebates than can amount to more than 50 percent of a drug’s sticker price to secure favorable coverage on PBM drug lists, and critics contend that firms like CVS keep an excessive slice of those undisclosed payments.